Clinical Phenotype and Rate of Glycaemic Deterioration Following Diagnosis of Type 2 Diabetes

被引:0
|
作者
Pearson, Ewan R.
Zhou, Kaixin
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1435-P
引用
收藏
页码:A373 / A374
页数:2
相关论文
共 50 条
  • [1] Identification of biomarkers for glycaemic deterioration in type 2 diabetes
    Roderick C. Slieker
    Louise A. Donnelly
    Elina Akalestou
    Livia Lopez-Noriega
    Rana Melhem
    Ayşim Güneş
    Frederic Abou Azar
    Alexander Efanov
    Eleni Georgiadou
    Hermine Muniangi-Muhitu
    Mahsa Sheikh
    Giuseppe N. Giordano
    Mikael Åkerlund
    Emma Ahlqvist
    Ashfaq Ali
    Karina Banasik
    Søren Brunak
    Marko Barovic
    Gerard A. Bouland
    Frédéric Burdet
    Mickaël Canouil
    Iulian Dragan
    Petra J. M. Elders
    Celine Fernandez
    Andreas Festa
    Hugo Fitipaldi
    Phillippe Froguel
    Valborg Gudmundsdottir
    Vilmundur Gudnason
    Mathias J. Gerl
    Amber A. van der Heijden
    Lori L. Jennings
    Michael K. Hansen
    Min Kim
    Isabelle Leclerc
    Christian Klose
    Dmitry Kuznetsov
    Dina Mansour Aly
    Florence Mehl
    Diana Marek
    Olle Melander
    Anne Niknejad
    Filip Ottosson
    Imre Pavo
    Kevin Duffin
    Samreen K. Syed
    Janice L. Shaw
    Over Cabrera
    Timothy J. Pullen
    Kai Simons
    Nature Communications, 14 (1)
  • [2] Identification of biomarkers for glycaemic deterioration in type 2 diabetes
    Slieker, Roderick C.
    Donnelly, Louise A.
    Akalestou, Elina
    Lopez-Noriega, Livia
    Melhem, Rana
    Gunes, Aysim
    Abou Azar, Frederic
    Efanov, Alexander
    Georgiadou, Eleni
    Muniangi-Muhitu, Hermine
    Sheikh, Mahsa
    Giordano, Giuseppe N.
    Akerlund, Mikael
    Ahlqvist, Emma
    Ali, Ashfaq
    Banasik, Karina
    Brunak, Soren
    Barovic, Marko
    Bouland, Gerard A.
    Burdet, Frederic
    Canouil, Mickael
    Dragan, Iulian
    Elders, Petra J. M.
    Fernandez, Celine
    Festa, Andreas
    Fitipaldi, Hugo
    Froguel, Phillippe
    Gudmundsdottir, Valborg
    Gudnason, Vilmundur
    Gerl, Mathias J.
    van der Heijden, Amber A.
    Jennings, Lori L.
    Hansen, Michael K.
    Kim, Min
    Leclerc, Isabelle
    Klose, Christian
    Kuznetsov, Dmitry
    Aly, Dina Mansour
    Mehl, Florence
    Marek, Diana
    Melander, Olle
    Niknejad, Anne
    Ottosson, Filip
    Pavo, Imre
    Duffin, Kevin
    Syed, Samreen K.
    Shaw, Janice L.
    Cabrera, Over
    Pullen, Timothy J.
    Simons, Kai
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [3] Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study
    Slieker, R. C.
    Donnelly, L. A.
    Lopez-Noriega, L.
    Giordano, G. N.
    Akerlund, M.
    Pavo, I.
    Lyssenko, V.
    Quigley, C. Legido
    Groop, L.
    Ibberson, M.
    Beulens, J. W. J.
    ' t Hart, L. M.
    Pearson, E. R.
    Rutter, G. A.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 108 - 108
  • [4] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
    Donnelly, Louise A.
    Zhou, Kaixin
    Doney, Alex S. F.
    Jennison, Chris
    Franks, Paul W.
    Pearson, Ewan R.
    DIABETOLOGIA, 2018, 61 (03) : 607 - 615
  • [5] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
    Louise A. Donnelly
    Kaixin Zhou
    Alex S. F. Doney
    Chris Jennison
    Paul W. Franks
    Ewan R. Pearson
    Diabetologia, 2018, 61 : 607 - 615
  • [6] Age at diagnosis predicts deterioration in glycaemic control among children and adolescents with type 1 diabetes
    Clements, Mark A.
    Lind, Marcus
    Raman, Sripriya
    Patton, Susana R.
    Lipska, Kasia J.
    Fridlington, Amanda G.
    Tang, Fengming
    Jones, Phil G.
    Wu, Yue
    Spertus, John A.
    Kosiborod, Mikhail
    BMJ OPEN DIABETES RESEARCH & CARE, 2014, 2 (01):
  • [7] Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial
    Zubin Punthakee
    Michael E. Miller
    Debra L. Simmons
    Matthew C. Riddle
    Faramarz Ismail-Beigi
    David J. Brillon
    Richard M. Bergenstal
    Peter J. Savage
    Irene Hramiak
    Joseph F. Largay
    Ajay Sood
    Hertzel C. Gerstein
    Diabetologia, 2014, 57 : 2030 - 2037
  • [8] Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial
    Punthakee, Zubin
    Miller, Michael E.
    Simmons, Debra L.
    Riddle, Matthew C.
    Ismail-Beigi, Faramarz
    Brillon, David J.
    Bergenstal, Richard M.
    Savage, Peter J.
    Hramiak, Irene
    Largay, Joseph F.
    Sood, Ajay
    Gerstein, Hertzel C.
    DIABETOLOGIA, 2014, 57 (10) : 2030 - 2037
  • [9] Phenotypic and genetic determinants of glycaemic deterioration among Asian Indian type 2 diabetes population
    Nair, A. Thakarakkattil Narayanan
    Donnelly, L. A.
    Dawed, A. Y.
    Gan, S.
    Anjana, R. M.
    Palmer, C. N. A.
    Mohan, V.
    Pearson, E. R.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 149 - 150
  • [10] Glycaemic management of type 2 diabetes
    Page, S
    CLINICAL MEDICINE, 2004, 4 (04) : 302 - 306